“…Especially endocrine complications occur frequently in CCSs. 2,3 These endocrine complications Abbreviations: AAD, alkylating agent dose; ALL, acute lymphoblastic leukemia; AMH, anti-Müllerian hormone; BMAD, bone mineral apparent density; BMD, bone mineral density; BMI, body mass index; CCS, childhood cancer survivor; DNA, deoxyribonucleic acid; DXA, dual x-ray absorptiometry; GWAS, genome-wide association study; LS, lumbar spine; MTX, methotrexate; SE, standard error; SNP, single-nucleotide polymorphism; SDS, standardized deviation score; TB, total body include an early impairment of bone mineral density (BMD) with consequent increased fracture risk, which can further result in disability and impairment of quality of life. 4,5 We and others described that low BMD in long-term adult CCSs is determined by male sex, younger age at diagnosis, older age at follow-up, underweight, and previous administered axial radiotherapy and steroids.…”